discontinuation 8/150 (5.3%); OR 2.30 (95% CI 1.01–5.22)], and remained within the same range after adjusting for maximum dose, treatment indication, and mono- versus polytherapy, but did not reach statistical significance (Table S8 ).
← all excerpts
Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort study.
1
—
—